Clinical Trial: A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Inflammatory Bowel Disease
Study Type: INTERVENTIONAL
Official Title: A Phase 4, Open-Label, Milk-Only Lactation Study to Assess Concentration of Risankizumab in Breast Milk of Lactating Women With Inflammatory Bowel Disease Who Are Receiving Risankizumab Therapeuticall
Brief Summary:
Inflammatory bowel disease (IBD) is a chronic inflammatory disease that requires lifelong treatment.This study will asses the concentrations of risankizumab in the breast milk of lactating women with IBDRisankizumab is an approved drug for adults with plaque psoriasis, psoriatic arthritis, and Crohn's Disease.This is an open-label milk-only study lactation study to evaluate the presence of risankizumab in the milk of lactating women.Approximately 10 adult lactating women with IBD will be enrolled from…
Read more